Genes in panel

Hereditary neuropathy or pain disorder

Gene: ATAD3A

Green List (high evidence)

ATAD3A (ATPase family, AAA domain containing 3A)
EnsemblGeneIds (GRCh38): ENSG00000197785
EnsemblGeneIds (GRCh37): ENSG00000197785
OMIM: 612316, Gene2Phenotype
ATAD3A is in 17 panels

2 reviews

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to green following NHS Genomic Medicine Service approval.
Created: 24 Feb 2025, 5:02 p.m. | Last Modified: 24 Feb 2025, 5:02 p.m.
Panel Version: 6.148
ATAD3A variants have been associated with Harel-Yoon syndrome, OMIM:617183. The de novo occurrence of rs1057517686 has been reported in five unrelated cases of OMIM:617183. and there two members of an Italian family were homozygous for variant rs1057517687 (PMID: 27640307)
Created: 4 Nov 2024, 11:26 a.m. | Last Modified: 4 Nov 2024, 11:26 a.m.
Panel Version: 6.20

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Harel-Yoon syndrome, OMIM:617183; Harel-Yoon syndrome, MONDO:0014958

Publications

Alexander Rossor (UCL Institute of Neurology)

Green List (high evidence)

Both de novo and recessive. Multiple unrelated indivudals reported with axonal neuropathy
Sources: Expert list
Created: 15 Oct 2024, 10:24 p.m.

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
global developmental delay; hypotonia; optic atrophy; axonal neuropathy; hypertrophic cardiomyopathy

Publications

Mode of pathogenicity
Other

History Filter Activity

24 Feb 2025, Gel status: 3

Removed Tag, Removed Tag

Sarah Leigh (Genomics England Curator)

Tag Q3_24_promote_green was removed from gene: ATAD3A. Tag Q3_24_NHS_review was removed from gene: ATAD3A.

24 Feb 2025, Gel status: 3

Added New Source, Added New Source, Status Update

Sarah Leigh (Genomics England Curator)

Source NHS GMS was added to ATAD3A. Source Expert Review Green was added to ATAD3A. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

4 Nov 2024, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: ATAD3A were changed from global developmental delay; hypotonia; optic atrophy; axonal neuropathy; hypertrophic cardiomyopathy to Harel-Yoon syndrome, OMIM:617183; Harel-Yoon syndrome, MONDO:0014958

4 Nov 2024, Gel status: 2

Added Tag, Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q3_24_promote_green tag was added to gene: ATAD3A. Tag Q3_24_NHS_review tag was added to gene: ATAD3A.

4 Nov 2024, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: atad3a has been classified as Amber List (Moderate Evidence).

15 Oct 2024, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance, Set mode of pathogenicity

Alexander Rossor (UCL Institute of Neurology)

gene: ATAD3A was added gene: ATAD3A was added to Hereditary neuropathy or pain disorder. Sources: Expert list Mode of inheritance for gene: ATAD3A was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: ATAD3A were set to 27640307 Phenotypes for gene: ATAD3A were set to global developmental delay; hypotonia; optic atrophy; axonal neuropathy; hypertrophic cardiomyopathy Penetrance for gene: ATAD3A were set to Complete Mode of pathogenicity for gene: ATAD3A was set to Other Review for gene: ATAD3A was set to GREEN